231 related articles for article (PubMed ID: 22613796)
1. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.
Chen DY; Balamurugan A; Ng HL; Cumberland WG; Yang OO
Blood; 2012 Jul; 120(1):100-11. PubMed ID: 22613796
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.
Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO
J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989
[TBL] [Abstract][Full Text] [Related]
3. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
4. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.
Adnan S; Balamurugan A; Trocha A; Bennett MS; Ng HL; Ali A; Brander C; Yang OO
Blood; 2006 Nov; 108(10):3414-9. PubMed ID: 16882705
[TBL] [Abstract][Full Text] [Related]
5. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
6. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
7. Switching and emergence of CTL epitopes in HIV-1 infection.
Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
[TBL] [Abstract][Full Text] [Related]
8. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
Rajapaksa US; Li D; Peng YC; McMichael AJ; Dong T; Xu XN
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13353-8. PubMed ID: 22826228
[TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Malhotra U; Kaushik S; Dar L; Mojumdar K; Chauhan NK; Sreenivas V
Med Microbiol Immunol; 2009 Feb; 198(1):47-56. PubMed ID: 18985383
[TBL] [Abstract][Full Text] [Related]
11. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
[TBL] [Abstract][Full Text] [Related]
12. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
13. The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.
Ranasinghe SR; Kramer HB; Wright C; Kessler BM; di Gleria K; Zhang Y; Gillespie GM; Blais ME; Culshaw A; Pichulik T; Simmons A; Rowland-Jones SL; McMichael AJ; Dong T
PLoS Pathog; 2011 May; 7(5):e1001341. PubMed ID: 21589893
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
16. Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo.
Lewis MJ; Balamurugan A; Ohno A; Kilpatrick S; Ng HL; Yang OO
J Immunol; 2008 Mar; 180(6):4075-81. PubMed ID: 18322217
[TBL] [Abstract][Full Text] [Related]
17. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
[TBL] [Abstract][Full Text] [Related]
18. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
[TBL] [Abstract][Full Text] [Related]
19. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
[TBL] [Abstract][Full Text] [Related]
20. CD8
Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]